Tips to reduce the risk of cancer

Share This Post


Although exact cause of cancer is still unknown and lot of research has been conducted to unearth this area, however lifestyle choices one makes does decides the consequences to a great extent. Here are some very simple lifestyle modifications will make big difference.

Foods to be taken during cancer treatment

  • Say no to tobacco – Smoking, usage of tobacco has been linked to many types of cancer. Even if one do not use tobacco its exposure can also result in cancer. One of the best decisions one can make is avoiding tobacco or smoking. This reduces the chances of catching cancer to a large extent.
  • Eat plenty of fruits and vegetables and have healthy food habits.
  • Avoid obesity. 
  • Use alcohol in moderation. 
  • Limited processed meat.
  • Be physically active and maintain a healthy body weight.
  • Protect yourself from the sun.
  • Get yourself immunized from Hepatitis B and HPV.
  • Practice safe sex.
  • Don’t share needles.
  • Get yourself medically checked every year after the age of 45.


For details on cancer treatment and second opinion, do call us at +91 96 1588 1588 or write to

Spread the love

Subscribe To Our Newsletter

Get updates and never miss a blog from Cancerfax

More To Explore

Development of CAR T Cell therapy in Korea
Cancer treatment in South Korea

Companies in Korea takes a step closer in developing home grown CAR T-Cell therapy

Due to high costs, treatments developed by multinational pharmaceutical corporations are difficult for Korean patients to access. As a result, Korean businesses have created and localised CAR-T treatments in an effort to address these issues. Many businesses have either begun developing CAR-T therapies or declared their intention to do so, including Curocell, Abclon, GC Cell, Ticaros, Helixmith, Toolgen, Cllengene, Eutilex, and Vaxcell Bio.

Spread the love
Blood cancer

Polatuzumab vedotin-piiq is approved by USFDA for previously untreated diffuse large B-cell lymphoma, not otherwise specified, and high-grade B-cell lymphoma

For adult patients with high-grade B-cell lymphoma (HGBL), not otherwise specified (NOS), or diffuse large B-cell lymphoma (DLBCL) who have not previously received treatment and who have an International Prognostic Index (IPI) score of 2 or higher, the Food and Drug Administration has approved polatuzumab vedotin-piiq (Polivy, Genentech, Inc.).

Spread the love

Need help? Our team is ready to assist you.

We wish a speedy recovery of your dear and near one.

درمان سرطان در تركيه

Enquiry Form